Transforming Allogeneic Cell Therapy for Blood, Genetic and Immune Diseases

Orca Bio is dedicated to developing high-precision allogeneic cell therapies designed to safely replace patients’ diseased blood and immune system with a healthy one.

open

Orca-T clinical data presented at 2021 TCT. View press release here

Bitnami